The present invention provides a pyrazole compound of the following general Formula [Ib] having SGLT1 inhibitory activity, or a pharmaceutically acceptable salt thereof, a pharmaceutical composition comprising the same, and its pharmaceutical use:
wherein each symbol is the same as defined in the description.
[EN] PROCESS FOR SYNTHESIS OF ORGANOSILICON COMPOUNDS FROM HALOSILANES<br/>[FR] PROCÉDÉ DE SYNTHÈSE DE COMPOSÉS D'ORGANOSILICIUM À PARTIR D'HALOSILANES
申请人:MOMENTIVE PERFORMANCE MAT INC
公开号:WO2022026307A1
公开(公告)日:2022-02-03
A process for synthesis of an organosilicon compound is provided herein. Also, novel organosilicon compounds prepared by the present process is provided herein. The process comprises the reaction of a halosilane with an organofunctional alkyl halide in the presence of a metal catalyst, a promoter, and an optional co-catalyst. The process provides an efficient synthetic route to produce organosilicon compounds. The process also allows synthesis of organosilicon compounds with a plurality of different functional groups.
Compound having formula I
and pharmaceutically acceptable salts or solvates thereof, their pharmaceutical formulations and use as HIV inhibitors.
化学式为I的化合物及其药学上可接受的盐或溶剂化物,它们的制药配方和用途是HIV抑制剂。
PYRAZOLE COMPOUND AND USE THEREOF FOR MEDICAL PURPOSES
申请人:Japan Tobacco, Inc.
公开号:EP2784074A1
公开(公告)日:2014-10-01
A compound of the following general Formula [Ib]:
, wherein each symbol is the same as defined in the description; or a pharmaceutically acceptable salt thereof.
以下通式[Ib]的化合物:
其中各符号与描述中定义的相同;或其药学上可接受的盐。
Aced, Ahmed; Anklam, Elke; Asmus, Klaus-Dieter, Phosphorus, Sulfur and Silicon and the Related Elements, 1990, vol. 48, # 1-4, p. 53 - 62
作者:Aced, Ahmed、Anklam, Elke、Asmus, Klaus-Dieter、Pohl, Klaus、Glass, Richard S.、et al.